New data released on Suzetrigine highlights its potential to reduce the need for postoperative opioids in patients recovering from surgery. This promising development could play a crucial role in addressing the ongoing opioid crisis by offering an effective alternative for pain management. The study suggests that patients taking Suzetrigine require fewer opioids post-surgery, leading to reduced risks associated with opioid use, such as addiction and side effects. As healthcare professionals continue to seek safer pain relief options, Suzetrigine’s emergence offers a significant step forward in pain management strategies. The findings encourage further research to solidify Suzetrigine’s role in postoperative care and its potential to transform pain treatment protocols. Healthcare providers and pharmacists alike are urged to stay informed about these advances to optimize patient care and improve recovery outcomes.
Pharmacy Practice NewsNew data shows a quarter of protected areas are in poor condition
May 28, 2026
Recent findings from the Royal Society for the Protection of Birds (RSPB) highlight a concerning trend: approximately 25% of the UK’s protected areas are reported